Production issues with Pfizer’s injectable version of naloxone, a lifesaving overdose reversal drug, has caused a shortage of the drug, affecting healthcare providers across the country, The Boston ...

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold ...

In the event of an opioid overdose, naloxone can restore normal breath to a person whose breathing has slowed or stopped — potentially saving a life, according to the National Institute on Drug Abuse.

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold ...

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...

Every 11 minutes someone in America dies from an opioid overdose. But there is a solution, public health officials say: Carry naloxone, even if you don’t think you know anyone who uses opioids.

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may ...

The U.S. Surgeon General issued a rare national advisory Thursday urging more Americans to carry naloxone, a drug used to revive people overdosing on opioids. Naloxone is a medication designed to ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. California can buy more ...

The US Food and Drug Administration (FDA) has granted final approval for the first generic naloxone hydrochloride nasal spray (Narcan, Teva Pharmaceuticals) that can stop or reverse the effects of an ...

LONDON, Aug. 20, 2024 /PRNewswire/ -- Hikma Pharmaceuticals in the US joined government officials and non-profit leaders today at a naloxone awareness and training event organized and hosted by Rep.